The most important events in healthcare in 2019 were the ones that didn’t happen. Access Experience Team member Todd Edgar explains why, with a focus on drug pricing and policy proposals.
Dan Danielson examines the impact of 2019 policy proposals changes on regional health plans, and notes that uncertainty from stakeholders has created the need for manufacturers to provide concise messaging that emphasizes value to payers.
Access Experience Team member Andrew Cournoyer looks at national health plans and the growing trend toward vertical integration and management of drugs covered under the medical benefit.
Team members Ryan Cox and Erin Lopata examine consolidation among health systems. Will this trend lead to lower costs and better care or should stakeholders be more concerned with the growing power of the industry heavyweights?